J&J Innovative Medicine

Learn how Johnson & Johnson is investigating a therapy for two alloantibody-driven diseases that can affect the lives of developing fetuses and newborn babies.

Plaque psoriasis is the most prevalent form of psoriasis, affecting millions worldwide. Johnson & Johnson is focused on developing novel therapies for chronic dermatologic diseases to address the unmet need that still exists.

Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.

Paul Reidy, a Johnson & Johnson warehouse technician in Ireland, never imagined that an oncology therapy made at the facility where he works would help save his life.

Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.

This complex type of cancer can cause malignancies of the mouth, throat, larynx and nasal cavity. Find out how Johnson & Johnson is innovating to change the current treatment paradigm.

This chronic inflammatory disease causes flareups that make it difficult to breathe. Learn about the two types of asthma, common triggers and how Johnson & Johnson is developing approaches that may lead to better treatments.

The company made the prestigious list for the 24th consecutive year, thanks to its dedication to innovation and social responsibility, among other criteria.

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.